Analystreport

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) had its price target lowered by analysts at Piper Sandler from $6.00 to $5.00. They now have an "overweight" rating on the stock.

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report